Fundz

Who to call at Path Fertility, and when

Fundz watches for the moments Path Fertility starts buying, and tells you who to reach.

  • An alert the day Path Fertility raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Path Fertility, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Path Fertility. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Path Fertility receives $2M SBIR grant from NIH to develop epigenetic diagnostics for male fertility and cancer risk assessment.

Nov 05, 2026
Salt Lake CityBiotechnologyHealth CareGeneticsHealth Diagnostics

Description

Path Fertility, a Salt Lake City-based molecular diagnostics company, received a $2M Direct to Phase II Small Business Innovation Research (SBIR) grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The grant will fund development and clinical validation of an epigenetic diagnostic for non-obstructive azoospermia (NOA) and associated cancer risk. Path Fertility's platform includes SpermQT, a clinically validated epigenetic sperm quality test, and NOA Guide, a diagnostic for predicting surgical sperm retrieval.

Company Information

Company

Path Fertility

Location

Salt Lake City, Utah, United States

About

Path Fertility is a Salt Lake City-based molecular diagnostics company advancing epigenetic testing for male fertility and reproductive health. The company offers SpermQT, a clinically validated epigenetic sperm quality test analyzing DNA methylation, and NOA Guide, a diagnostic for predicting surgical sperm retrieval in men with non-obstructive azoospermia. Led by CEO Andy Olson and CSO Kristin Brogaard, Path Fertility validates assays in CLIA-certified laboratory environments for commercial launch as laboratory developed tests.

Related People

Andy
Senior decision-maker at this company
••••••••@••••••••

See Andy's verified email →

Eric
Likely contact at this company
••••••••@••••••••

See Eric's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Path Fertility's next move

Learn about Strategic plan

Path Fertility signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.